- Hidradenitis Suppurativa and Treatments
- Anorectal Disease Treatments and Outcomes
- CAR-T cell therapy research
- Colorectal and Anal Carcinomas
- Eosinophilic Disorders and Syndromes
- Cancer Immunotherapy and Biomarkers
- Nonmelanoma Skin Cancer Studies
- Migration, Identity, and Health
- Skin Diseases and Diabetes
- Dermatology and Skin Diseases
- Medicine and Dermatology Studies History
- Dermatological and COVID-19 studies
- Cutaneous lymphoproliferative disorders research
- Sympathectomy and Hyperhidrosis Treatments
- Liver Disease Diagnosis and Treatment
- Inflammatory Myopathies and Dermatomyositis
- Cancer survivorship and care
- Occupational and environmental lung diseases
- Neonatal skin health care
- Radiomics and Machine Learning in Medical Imaging
- Cutaneous Melanoma Detection and Management
- Milk Quality and Mastitis in Dairy Cows
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- Microscopic Colitis
Hospital Universitario La Paz
2017-2024
Université de Reims Champagne-Ardenne
2016-2021
Centre Hospitalier Universitaire de Reims
2016-2021
Parc de Salut
2021
Hôpital Maison Blanche
2016
King's College Hospital
2006
Sapienza University of Rome
2006
Although cemiplimab has been approved for locally advanced (la) and metastatic (m) cutaneous squamous-cell carcinomas (CSCCs), its real-life value not yet demonstrated. An early-access program enrolled patients with la/mCSCCs to receive cemiplimab. Endpoints were best overall response rate (BOR), progression-free survival (PFS), (OS), duration of (DOR) safety. The 245 (mean age 77 years, 73% male, 49% prior systemic treatment, 24% immunocompromised, 27% Eastern Cooperative Oncology Group...
Abstract Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicle, associated with considerable tissue remodelling. Although abnormal cytokine expression was detected both in perilesional and uninvolved skin, up to now there no model allowing better understanding implicit inflammatory mechanisms HS. The aim this study investigate response HS by mean an ex vivo culture. To that purpose, nine biopsy specimens from patients...
Abstract Background The prognosis of unresectable cutaneous squamous cell carcinomas is very poor. Objective To evaluate the efficacy and safety panitumumab alone or in association with radiotherapy treatment carcinoma. Methods This was a monocentre retrospective study all consecutive patients having received at least two courses panitumumab, radiotherapy, between 2016 2019. primary endpoint rate best overall response, evaluated according to RECIST 1.1 criteria. secondary endpoints were...
Despite advancements in personalized cancer therapies, platinum-based chemotherapy remains the cornerstone for treating solid tumors, including Non-Small Cell Lung Cancer (NSCLC). The integration of novel immunotherapies with platinum compounds has shown promising outcomes treatment advanced disease. However, a significant proportion patients experience therapeutic failure due to innate or acquired resistance. Thus, identifying molecular profiles and biomarkers monitor patient progress...
Objectives Calcium depositions are frequent in multiple inflammatory dermatosis, they can be explored by ultrasound (US) but the patterns of these have not yet been described. The aim this study is to describe different calcium deposition dermatoses. Methods clinical and US data 58 patients from 7 centers with dermatosis showing ultrasonography‐detected was retrospectively reviewed. Results Dystrophic calcinosis represented 86.2%, calciphylaxis 8.6%, metastatic 5.2%. Three sonographic were...
e23007 Background: The aim of our study was to determine if an unscheduled hospitalization in advanced cancer patients is a good time for palliative care referrals, and this indicator could be improved with some other prognostic score. Methods: We conducted retrospective study, which included all the medical oncology service from January 2011 December 2013. In order improve accuracy analysis we considered only first admissions each patient. excluded scheduled unindicated hospitalization....